The data obtained with the PAR1-null mice revealed a novel anti-inflammatory non-PAR1 effect of TFLLR-NH2 (but not its reverse-sequence peptide) in a mouse model of nonbacterial prostatitis. The gene discussed is F2R; the disease is male reproductive organ cancer.